Difference between revisions of "CD99"
Jump to navigation
Jump to search
(create) |
|||
| Line 3: | Line 3: | ||
==Positive== | ==Positive== | ||
*[[Malignant melanoma]] (9 of 10 cases<ref name=pmid11789717>{{Cite journal | last1 = Monteagudo | first1 = C. | last2 = Calduch | first2 = L. | last3 = Navarro | first3 = S. | last4 = Joan-Figueroa | first4 = A. | last5 = Llombart-Bosch | first5 = A. | title = CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. | journal = Am J Clin Pathol | volume = 117 | issue = 1 | pages = 126-31 | month = Jan | year = 2002 | doi = 10.1309/2EXB-70CW-3U6P-VQ6H | PMID = 11789717 }}</ref>). | *[[Malignant melanoma]] (9 of 10 cases<ref name=pmid11789717>{{Cite journal | last1 = Monteagudo | first1 = C. | last2 = Calduch | first2 = L. | last3 = Navarro | first3 = S. | last4 = Joan-Figueroa | first4 = A. | last5 = Llombart-Bosch | first5 = A. | title = CD99 immunoreactivity in atypical fibroxanthoma: a common feature of diagnostic value. | journal = Am J Clin Pathol | volume = 117 | issue = 1 | pages = 126-31 | month = Jan | year = 2002 | doi = 10.1309/2EXB-70CW-3U6P-VQ6H | PMID = 11789717 }}</ref>). | ||
*[[Atypical fibroxanthoma]] (19 of 26 cases<ref name=pmid11789717>). | *[[Atypical fibroxanthoma]] (19 of 26 cases<ref name=pmid11789717/>). | ||
==See also== | ==See also== | ||
Revision as of 12:33, 15 October 2015
CD99 is a commonly available immunostain with various uses.
Positive
- Malignant melanoma (9 of 10 cases[1]).
- Atypical fibroxanthoma (19 of 26 cases[1]).